Black Hawk Acquisition Corporation (NASDAQ:BKHAU) announced the pricing of its upsized $69 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “BKHAU”, Thursday, March 21, 2024.
The new SPAC will have a broad search focus and will not be limited to a particular geographic region or industry.
Black Hawk’s sponsor team will be led by Kent Louis Kaufman, as Chairman, Chief Executive Officer, Chief Financial Officer, and Director. Brandon Miller, Daniel M. McCabe and Terry W. Protto, are each to serve as independent directors.
Total SPAC deal count for 2024 year-to-date is now 5. This offering is expected to close on Friday, March 22, 2024.
EF Hutton LLC is the sole book-running manager for the IPO. Celine and Partners, P.L.L.C. is serving as Issuer’s Counsel with Robinson & Cole LLP serving as Underwriter’s Counsel. MaloneBailey, LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
Terms Tracker for the Week Ending May 3, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. The big news this week was that SPACs finally had a new IPO price with Churchill Capital Corp. IX’s $250 million offering on Thursday. SPACs...
Real estate marketplace Opendoor (NASDAQ:OPEN) is poised to be the latest de-SPAC to take a double-digit jump on earnings as it heads towards the weekend up +10%, having spiked as high as +27% earlier in the day. The movement comes as the former Social Capital II target reported progress towards profitability despite a high rates...
At the SPAC of Dawn Coinbase (NASDAQ:COIN) notched a surprise profit of over $1.5 billion in the first quarter of 2024, well exceeding estimates, demonstrating the powerful effect of publicly traded ETFs have had on crypto marketplaces since the start of the year. The result has pushed the company to bump up its own guidance...
Online casino and sports company Rush Street (NYSE:RSI) is up +18.4% in trading today on the back of a solid first quarter earnings release, bringing the company’s stock to its highest price since the second half of 2022 (currently $7.60). This makes it the latest in a line of 2020 and 2021 de-SPACs that have...
Mountain Crest V (NASDAQ:MCAG) broke a long dealmaking silence by SPACs this morning, albeit with a non-binding agreement to combine with Seoul-based diagnostic biotech firm CUBEBIO. The term sheet would give the company a $620 million pre-transaction equity value and help accelerate the rollout of CUBEBIO’s CEED-NOVUS cancer screening kit products. The company signed an...